search
Back to results

Lymphedema Prevention in Breast Cancer

Primary Purpose

BREAST CANCER, LYMPHEDEMA

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Early Physical Therapy and Educational strategy
Sponsored by
University of Alcala
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for BREAST CANCER focused on measuring Lymphedema, Prevention, Breast cancer, Physical therapy

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Consecutive women diagnosed with breast cancer and undergoing unilateral surgery with axillary lymph-node dissection at the Príncipe de Asturias Hospital in Alcalá de Henares, Madrid (Spain) are candidates for inclusion in the study.

Exclusion Criteria:

  • Patients without axillary lymph-node dissection or with bilateral BC, systemic disease, locoregional recurrence, or any contraindication to physical therapy are excluded from the study.

Sites / Locations

  • Alcalá University
  • María Torres Lacomba

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

1

2

Arm Description

Early Physical Therapy including a manual lymph-drainage technique, progressive massage of the scar, and progressive active and action-assisted shoulder exercises started in conjunction with functional activities and proprioceptive neuromuscular facilitation without resistance and educational strategy including instruction with printed materials about the lymphatic system, concepts of normal load versus overload, lymphedema source, the identification of possible precipitating factors, etc.

Educational Strategy: instruction with printed materials about the lymphatic system, concepts of normal load versus overload, lymphedema source, the identification of possible precipitating factors, etc.

Outcomes

Primary Outcome Measures

Circumference measurements of the upper limbs using at 5 cm intervals from the elbow fold preoperatively prior to randomization and then post-operatively on hospital discharge (between Day 3 and Day 5), 4 weeks, and 3, 6, 12 and 24 months after surgery.

Secondary Outcome Measures

Pain, measured using the Visual Analogue Scale and Shoulder abduction measured using a digital goniometer.

Full Information

First Posted
September 25, 2008
Last Updated
August 22, 2014
Sponsor
University of Alcala
search

1. Study Identification

Unique Protocol Identification Number
NCT00760123
Brief Title
Lymphedema Prevention in Breast Cancer
Official Title
Lymphedema Prevention in Breast Cancer: a Simple Blind, Randomized, Prospective Clinical Trial of the Efficacy of Physical Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Completed
Study Start Date
May 2005 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alcala

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
OBJECTIVE: To find out the effectiveness of early application of physical therapy in the prevention of lymphedema after breast surgery and lymphadenectomy. DESIGN: Randomized, controlled and single blinded clinical trial. Three years duration. Patients will be randomly assigned to one of these groups: Experimental group: Early physical therapy + training in means of prevention; Control group: just training in means of prevention. In both groups several physical therapy assessments will be undertaken: 1st before surgery; 2nd immediately after surgery; 3rd after completing intervention; 4th, 5th and 6th after 3, 6, 12 and 24 months. SUBJECTS: Women with breast cancer treated with breast surgery including lymphadenectomy in Principe de Asturias Hospital, provided that there is no contraindication for physical therapy, and after reading, understanding and freely signing an informed consent form. SAMPLE SIZE: A total of 116 subjects will be included in the study (58 subjects in each group), assuming a 15% of drop-outs and at least 20% reduction, with a statistical power of 60%. DATA ANALYSIS: To find out the effectiveness of intervention we will compare the rate of lymphedema in both groups by means of a logistic regression analysis, in which the main factor is the intervention group. Other factors aimed to control the effect of the intervention will also be included. In order to compare the rate of appearance of lymphedema in both groups, a survival analysis will also be included.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
BREAST CANCER, LYMPHEDEMA
Keywords
Lymphedema, Prevention, Breast cancer, Physical therapy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Early Physical Therapy including a manual lymph-drainage technique, progressive massage of the scar, and progressive active and action-assisted shoulder exercises started in conjunction with functional activities and proprioceptive neuromuscular facilitation without resistance and educational strategy including instruction with printed materials about the lymphatic system, concepts of normal load versus overload, lymphedema source, the identification of possible precipitating factors, etc.
Arm Title
2
Arm Type
Other
Arm Description
Educational Strategy: instruction with printed materials about the lymphatic system, concepts of normal load versus overload, lymphedema source, the identification of possible precipitating factors, etc.
Intervention Type
Other
Intervention Name(s)
Early Physical Therapy and Educational strategy
Intervention Description
Experimental group: physical therapy including a manual lymph-drainage technique, progressive massage of the scar, and progressive active and action-assisted shoulder exercises started in conjunction with functional activities and proprioceptive neuromuscular facilitation without resistance and Educational strategy including instruction with printed materials about the lymphatic system, concepts of normal load versus overload, lymphedema source, the identification of possible precipitating factors,etc. Other: control group: only the educational strategy
Primary Outcome Measure Information:
Title
Circumference measurements of the upper limbs using at 5 cm intervals from the elbow fold preoperatively prior to randomization and then post-operatively on hospital discharge (between Day 3 and Day 5), 4 weeks, and 3, 6, 12 and 24 months after surgery.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Pain, measured using the Visual Analogue Scale and Shoulder abduction measured using a digital goniometer.
Time Frame
2 years

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Consecutive women diagnosed with breast cancer and undergoing unilateral surgery with axillary lymph-node dissection at the Príncipe de Asturias Hospital in Alcalá de Henares, Madrid (Spain) are candidates for inclusion in the study. Exclusion Criteria: Patients without axillary lymph-node dissection or with bilateral BC, systemic disease, locoregional recurrence, or any contraindication to physical therapy are excluded from the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María Torres Lacomba, Prof.
Organizational Affiliation
Alcalá University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maria José Yuste Sánchez, Prof.
Organizational Affiliation
Alcalá University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Álvaro Zapico Goñi, MD
Organizational Affiliation
Principe de Asturias Hospital University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
David Prieto Merino
Organizational Affiliation
Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, UK
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Orlando Mayoral del Moral, Prof.
Organizational Affiliation
Provincial Hospital.
Official's Role
Study Chair
Facility Information:
Facility Name
Alcalá University
City
Alcalá de Henares
State/Province
Madrid
ZIP/Postal Code
28871
Country
Spain
Facility Name
María Torres Lacomba
City
Alcalá de Henares
State/Province
Madrid
ZIP/Postal Code
28871
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
18428212
Citation
Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008 Jun 15;112(12):2809-19. doi: 10.1002/cncr.23494.
Results Reference
background

Learn more about this trial

Lymphedema Prevention in Breast Cancer

We'll reach out to this number within 24 hrs